There are 2789 resources available
1028TiP - ARC-12: Phase I/Ib dose escalation and dose expansion study to evaluate the safety and tolerability of AB308 + zimberelimab (AB122) in advanced malignancies
Presenter: Justin Call
Session: ePoster Display
1013P - Similar overall survival in tebentafusp-treated 2L+ metastatic uveal melanoma regardless of prior immunotherapy
Presenter: Josep M. Piulats
Session: ePoster Display
1014P - Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in previously untreated patients with metastatic uveal melanoma
Presenter: April Salama
Session: ePoster Display
1015P - A phase I dose-escalation study of HBM4003: An anti-CTLA-4 heavy-chain-only mAb
Presenter: Paul de Souza
Session: ePoster Display
1016P - ImmTAC redirect exhausted tumor-infiltrating T-cells: An effect enhanced by pembrolizumab against PD-L1+ tumors
Presenter: Kristina Petrovic
Session: ePoster Display
1017P - Preclinical evaluation of KD033, a human anti-PD-L1/IL-15 bispecific protein, in human PD-1/PD-L1 transgenic C57/Bl6 mice with PD-L1 positive and negative tumors
Presenter: Stella Martomo
Session: ePoster Display
CN3 - The effect of using interactive mobile application for management of chemotherapy induced nausea and vomiting in children: Randomized controlled study
Presenter: Remziye Semerci
Session: ePoster Display
918P - Impact of locally advanced head and neck cancer treatment: Is there a role for exercise? FIT4TREAT
Presenter: Ines Leao
Session: ePoster Display
919P - Survival impact of nutritional status of locally advanced head and neck cancer squamous cell carcinoma (HNSCC) patients treated with chemoradiotherapy: A prospective observational study
Presenter: Ratchadakorn Meesart
Session: ePoster Display